Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed IR price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$74.00
Today
Analyst consensus
$95.43
+28.96% · 12M
2030 Base
—
— future
NPV today
—
@ — WACC
7 analysts:
3 Buy3 Hold0 Sell
Management guidance
No specific CEO revenue targets provided in available research. Latest guidance from Q4 2025 earnings indicates continued focus on recurring revenue growth from aftermarket services and M&A strategy (Scinomix, Transvac acquisitions). Company maintaining operational guidance but facing tariff headwinds and delayed pricing realization.
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
—
NPV today: —
Base case (2030)
—
NPV today: —
Bull case (2030)
—
NPV today: —
WallStSmart.com
IR financial forecast · Research-backed projections
Metric
2025
2026 (E)
2027 (E)
2028 (E)
2029 (E)
2030 (E) ★
Revenue
$7.7B
$8.2B
$8.6B
$9.1B
$9.5B
$10.0B
Revenue growth
5.7%
7.1%
4.9%
5.2%
5.2%
5.1%
Net margin
—
—
—
—
—
—
EPS
$3.34
$3.65
$4.02
$4.45
$4.75
$5.10
Diluted shares
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
P/S multiple
—
2.0x
2.0x
2.0x
2.0x
2.0x
Implied price (base)
—
$249.31
$264.89
$272.69
$288.27
$303.85
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
2030E driver
Bear
Base
Bull
Revenue
$10.0B
$10.0B
$10.0B
P/S multiple
1.0x
2.0x
4.0x
Diluted shares
0M
0M
0M
Net debt
—
—
—
Implied P/E †
—
—
—
2030 Price
$—
$—
$—
NPV @ —
$—
$—
$—
† Implied P/E: Multiples remain elevated across all three scenarios because IR is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $— base case
IR catalysts and risks
Growth catalysts
+ Scinomix and Transvac acquisitions driving life sciences and ejector technology revenue expansion
- High current P/E of 53.7x reflects elevated market expectations; earnings growth must justify valuation
- EPS showing volatility (TTM -29.38% Y/Y), indicating one-time items or margin pressure in 2025
- Industrial cyclicality and potential macroeconomic slowdown could impact capital equipment demand
Methodology · Ingersoll Rand Inc 2030 stock forecast model
Ingersoll Rand Inc 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 7 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
1. Share dilution
Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (-100% cumulative for IR by 2030)
2. Net debt
EV minus net debt yields equity value; debt projected from capex cycle trajectory (— by 2030)
3. Time value
NPV calculated using — WACC (sector fallback)
4. Multiple framework
P/S compresses with scale: bear 1.0x / base 2.0x / bull 4.0x
5. Scenario design
Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.
IR price target FAQ
How is the Ingersoll Rand Inc 2030 stock forecast calculated?
The IR 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
What is the analyst consensus on IR stock?
7 analysts cover IR with an average 12-month price target of $95.43. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.